Jefferies lifts it price target on Jazz Pharmaceuticals (JAZZ) to $64 from $56 on its belief...

|About: Jazz Pharmaceuticals, Inc. (JAZZ)|By:, SA News Editor

Jefferies lifts it price target on Jazz Pharmaceuticals (JAZZ) to $64 from $56 on its belief that the firm can beat its own guidance with its reconfigured sales structure. Analysts also raise their EPS estimates for Jazz for FY12 and FY13 by $0.04 and $0.73, respectively.